X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs AUROBINDO PHARMA - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA AUROBINDO PHARMA FULFORD INDIA/
AUROBINDO PHARMA
 
P/E (TTM) x 398.8 14.3 2,779.4% View Chart
P/BV x 6.2 3.7 167.6% View Chart
Dividend Yield % 0.1 0.4 20.1%  

Financials

 FULFORD INDIA   AUROBINDO PHARMA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
AUROBINDO PHARMA
Mar-17
FULFORD INDIA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs942895 105.3%   
Low Rs450622 72.3%   
Sales per share (Unadj.) Rs691.4254.6 271.6%  
Earnings per share (Unadj.) Rs11.539.3 29.2%  
Cash flow per share (Unadj.) Rs15.446.6 33.0%  
Dividends per share (Unadj.) Rs2.002.50 80.0%  
Dividend yield (eoy) %0.30.3 87.2%  
Book value per share (Unadj.) Rs380.0160.0 237.6%  
Shares outstanding (eoy) m3.90585.88 0.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.03.0 33.8%   
Avg P/E ratio x60.719.3 314.5%  
P/CF ratio (eoy) x45.316.3 278.3%  
Price / Book Value ratio x1.84.7 38.6%  
Dividend payout %17.46.4 274.2%   
Avg Mkt Cap Rs m2,714444,390 0.6%   
No. of employees `0000.414.0 3.2%   
Total wages/salary Rs m50517,678 2.9%   
Avg. sales/employee Rs Th6,073.010,667.8 56.9%   
Avg. wages/employee Rs Th1,137.41,264.3 90.0%   
Avg. net profit/employee Rs Th100.71,645.8 6.1%   
INCOME DATA
Net Sales Rs m2,696149,157 1.8%  
Other income Rs m1251,159 10.8%   
Total revenues Rs m2,822150,316 1.9%   
Gross profit Rs m-4634,343 -0.1%  
Depreciation Rs m154,276 0.4%   
Interest Rs m10667 1.4%   
Profit before tax Rs m5430,558 0.2%   
Minority Interest Rs m050 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m107,597 0.1%   
Profit after tax Rs m4523,012 0.2%  
Gross profit margin %-1.723.0 -7.5%  
Effective tax rate %17.724.9 71.1%   
Net profit margin %1.715.4 10.7%  
BALANCE SHEET DATA
Current assets Rs m1,73892,062 1.9%   
Current liabilities Rs m54566,223 0.8%   
Net working cap to sales %44.317.3 255.5%  
Current ratio x3.21.4 229.6%  
Inventory Days Days48106 45.7%  
Debtors Days Days468 6.4%  
Net fixed assets Rs m1262,919 0.0%   
Share capital Rs m39586 6.7%   
"Free" reserves Rs m1,44393,133 1.5%   
Net worth Rs m1,48293,719 1.6%   
Long term debt Rs m01,814 0.0%   
Total assets Rs m2,077162,494 1.3%  
Interest coverage x6.746.8 14.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.9 141.5%   
Return on assets %2.614.6 17.9%  
Return on equity %3.024.6 12.3%  
Return on capital %4.332.7 13.1%  
Exports to sales %00-   
Imports to sales %24.50-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m659NA-   
Fx inflow Rs m1775,838 0.0%   
Fx outflow Rs m67330,224 2.2%   
Net fx Rs m-65645,613 -1.4%   
CASH FLOW
From Operations Rs m9032,786 0.3%  
From Investments Rs m105-17,870 -0.6%  
From Financial Activity Rs m-14-19,153 0.1%  
Net Cashflow Rs m181-4,239 -4.3%  

Share Holding

Indian Promoters % 0.0 54.1 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 8.0 47.8%  
FIIs % 0.1 27.7 0.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 10.2 207.8%  
Shareholders   4,783 69,601 6.9%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   MERCK LTD  CIPLA  TORRENT PHARMA  ALEMBIC LTD  WYETH LTD  

Compare FULFORD INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Up; ONGC & Tata Steel Top Gainers(Closing)

Indian share markets ended the day on a strong note. At the closing bell, the BSE Sensex finished higher by 262 points. While, the NSE Nifty finished up by 91 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA - TORRENT PHARMA COMPARISON

COMPARE FULFORD INDIA WITH

MARKET STATS